These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33950212)

  • 21. Common drugs can harm elderly patients.
    Voelker R
    JAMA; 2009 Aug; 302(6):614-5. PubMed ID: 19671895
    [No Abstract]   [Full Text] [Related]  

  • 22. [Risk of vitamin K antagonists in cases of cerebral microbleeds].
    Verhaar BJH; Vernooij MW; Biessels GJ; Muller M
    Ned Tijdschr Geneeskd; 2018; 162():D1790. PubMed ID: 29424326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab.
    Qureshi AI; Saad M; Zaidat OO; Suarez JI; Alexander MJ; Fareed M; Suri K; Ali Z; Hopkins LN
    Stroke; 2002 Jul; 33(7):1916-9. PubMed ID: 12105375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral microbleeds on T2*-weighted images and hemorrhagic transformation after antithrombotic therapies for ischemic stroke.
    Takahashi W; Moriya Y; Mizuma A; Uesugi T; Ohnuki Y; Takizawa S
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e528-32. PubMed ID: 23830955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primum non nocere: antithombotics after intracerebral hemorrhage?
    Goldstein LB
    Neurology; 2006 Jan; 66(2):162-3. PubMed ID: 16434646
    [No Abstract]   [Full Text] [Related]  

  • 26. Antithrombotic therapy influences location, enlargement, and mortality from intracerebral hemorrhage. The Bleeding with Antithrombotic Therapy (BAT) Retrospective Study.
    Toyoda K; Yasaka M; Nagata K; Nagao T; Gotoh J; Sakamoto T; Uchiyama S; Minematsu K;
    Cerebrovasc Dis; 2009; 27(2):151-9. PubMed ID: 19039219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracranial hemorrhage--a too common adverse effect of anticoagulants?].
    Rasmussen IB; Persson L
    Lakartidningen; 1989 Feb; 86(7):535-6. PubMed ID: 2918792
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resumption of antithrombotic treatment after an intracerebral haemorrhage].
    Kappelle LJ; Hofmeijer J; Chamuleau SA; van Nieuwenhuizen KM; Hemels ME; Klijn CJ
    Ned Tijdschr Geneeskd; 2015; 159():A8507. PubMed ID: 25873219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
    Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
    Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies.
    Lauer A; Pfeilschifter W; Schaffer CB; Lo EH; Foerch C
    Lancet Neurol; 2013 Apr; 12(4):394-405. PubMed ID: 23518332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intracerebral hemorrhage and serum sickness after thrombolytic treatment in myocardial infarction].
    Kierkegaard A
    Lakartidningen; 1991 Sep; 88(38):3069-70. PubMed ID: 1921594
    [No Abstract]   [Full Text] [Related]  

  • 32. New anticoagulants in ischemic heart disease.
    Verheugt FW
    Presse Med; 2005 Oct; 34(18):1325-9. PubMed ID: 16269997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antithrombotic agents].
    Yamazaki M; Uchiyama S
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():231-8. PubMed ID: 23156514
    [No Abstract]   [Full Text] [Related]  

  • 34. Danger of treatment protocols.
    Cucchiara B; Messé S; Kasner SE
    Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
    [No Abstract]   [Full Text] [Related]  

  • 35. Letter by Kurnik et al regarding article, "antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations".
    Schwammenthal Y; Tanne D; Kurnik D
    Stroke; 2013 May; 44(5):e52. PubMed ID: 23549136
    [No Abstract]   [Full Text] [Related]  

  • 36. [Risk of intracerebral hematoma and profibrinolytic activity of isotretinoin].
    Amalfitano G; Pernod G; Mallaret M; Barjhoux C; Berger F; Besson G; Pasquier B
    Therapie; 1995; 50(5):479-81. PubMed ID: 8571296
    [No Abstract]   [Full Text] [Related]  

  • 37. European Stroke Conference, Glasgow, UK, May 29-June 1, 2007.
    Quinn TJ; Lees KR
    Int J Stroke; 2007 Nov; 2(4):297-8. PubMed ID: 18705934
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to letter regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome".
    Kellert L; Hametner C; Stampfl S
    Stroke; 2013 Sep; 44(9):e113. PubMed ID: 23929751
    [No Abstract]   [Full Text] [Related]  

  • 39. Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation.
    Burchell SR; Tang J; Zhang JH
    Curr Drug Targets; 2017; 18(12):1329-1344. PubMed ID: 28378693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cerebral hemorrhage and Gerstmann syndrome as a complication of fibrinolytic therapy].
    Modrego Pardo PJ; Revilla Martín MA; Duato Jane A; Civeira Murillo E
    Neurologia; 1991 Apr; 6(4):151-2. PubMed ID: 2064796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.